Login / Signup

Temperature-controlled laminar airflow (TLA) device in the treatment of children with severe atopic eczema: Open-label, proof-of-concept study.

Claudia GoreR B GoreS FontanellaS HaiderA Custovic
Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2018)
Addition of TLA device to standard pharmacological treatment may be an effective add-on to the management of difficult-to-control AE.
Keyphrases
  • open label
  • clinical trial
  • young adults
  • squamous cell carcinoma
  • atopic dermatitis
  • phase ii
  • phase ii study
  • phase iii
  • locally advanced